EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Pulmatrix Names James Roach Chief Medical Officer

Xconomy Boston — 

James Roach has been appointed chief medical officer of Lexington, MA-based Pulmatrix (NASDAQ: PULM). Roach joins Pulmatrix from Southborough, MA-based Veristat, where he was chief medical officer. Pulmatrix develops inhaled drugs for serious lung diseases. Roach will start his new role on Nov. 3.